A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients

NCT03950414 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Insufficient Patient Population

Conditions

Cytomegalovirus Infections
Solid Organ Transplant

Interventions

BIOLOGICAL: CMV specific T-cells

Sponsor

University of Wisconsin, Madison